Martina Daga

1.9k total citations
24 papers, 1.5k citations indexed

About

Martina Daga is a scholar working on Molecular Biology, Cell Biology and Biomedical Engineering. According to data from OpenAlex, Martina Daga has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Cell Biology and 6 papers in Biomedical Engineering. Recurrent topics in Martina Daga's work include Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Martina Daga is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Martina Daga collaborates with scholars based in Italy, United States and United Kingdom. Martina Daga's co-authors include Giuseppina Barrera, Stefania Pizzimenti, Chiara Dianzani, Fabrizio Gentile, Alessia Arcaro, Eric Ciamporcero, Alessio Lepore, Giovanni Paolo Cetrangolo, Piergiorgio Pettazzoni and Graf M and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Free Radical Biology and Medicine.

In The Last Decade

Martina Daga

24 papers receiving 1.5k citations

Peers

Countries citing papers authored by Martina Daga

Since Specialization

Citations

This map shows the geographic impact of Martina Daga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Daga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Daga more than expected).

Fields of papers citing papers by Martina Daga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Daga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Daga. The network helps show where Martina Daga may publish in the future.

Co-authorship network of co-authors of Martina Daga

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Daga. A scholar is included among the top collaborators of Martina Daga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Daga. Martina Daga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver 2020 ·Toxicology in Vitro ·Martina Daga, Inge A.M. de Graaf, Monica Argenziano, (unknown), (unknown), (unknown), Marie Angèle Cucci, Fabrizio Caldera, Francesco Trotta, Giuseppina Barrera, Angela Casini, Roberta Cavalli, Stefania Pizzimenti	44
2	Flow Cytometry in Chronic Myelogenous Leukemia Blast Crisis 2020 ·(unknown), Sarika Singh, Pallavi Sinha, (unknown), (unknown), (unknown), Martina Daga	1
3	Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells 2019 ·Molecular and Cellular Biochemistry ·(unknown), (unknown), (unknown), Stefania Pizzimenti, Marie Angèle Cucci, Martina Daga, Giuseppina Barrera, Zbigniew Pasieka, Kamila Czarnecka, Paweł Szymański	28
4	Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 2019 ·Free Radical Biology and Medicine ·Marie Angèle Cucci, Alessandra Compagnone, Martina Daga, Margherita Grattarola, Chiara Ullio, Antonella Roetto, (unknown), Arianna Carolina Rosa, Monica Argenziano, Roberta Cavalli, Maria M. Simile, Rosa M. Pascale, Chiara Dianzani, Giuseppina Barrera, Stefania Pizzimenti	16
5	Multiple catalytic activities of human 17β-hydroxysteroid dehydrogenase type 7 respond differently to inhibitors 2019 ·Biochimie ·(unknown), Salvatore Adinolfi, (unknown), Donald Poirier, Martina Daga, Marco L. Lolli, Gianni Balliano, Francesca Spyrakis, Simonetta Oliaro‐Bosso	8
6	Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression. 2018 ·Phytomedicine ·Martina Daga, Stefania Pizzimenti, Chiara Dianzani, Marie Angèle Cucci, Roberta Cavalli, Margherita Grattarola, Benedetta Ferrara, Valentina Scariot, Francesco Trotta, Giuseppina Barrera	62
7	Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 2017 ·Free Radical Biology and Medicine ·Eric Ciamporcero, Martina Daga, Stefania Pizzimenti, Antonella Roetto, Chiara Dianzani, Alessandra Compagnone, (unknown), Chiara Ullio, (unknown), Роберто Пили, Giuseppina Barrera	67
8	KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease 2017 ·Free Radical Biology and Medicine ·Cinzia Antognelli, Eliana Trapani, Simona Delle Monache, Andrea Perrelli, Martina Daga, Stefania Pizzimenti, Giuseppina Barrera, Paola Cassoni, Adriano Angelucci, Lorenza Trabalzini, Vincenzo Nicola Talesa, Luca Goitre, Saverio Francesco Retta	67
9	DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity 2017 ·SHILAP Revista de lepidopterología ·Fabrizio Gentile, Alessia Arcaro, Stefania Pizzimenti, Martina Daga, Giovanni Paolo Cetrangolo, Chiara Dianzani, Alessio Lepore, Graf M, Paul R. J. Ames, Giuseppina Barrera	147
10	Aldehydes Derived from Lipid Peroxidation in Cancer and Autoimmunity 2017 ·Giuseppina Barrera, Stefania Pizzimenti, Martina Daga, Chiara Dianzani, Giovanni Paolo Cetrangolo, Alessio Lepore, Alessia Arcaro, Fabrizio Gentile	3
11	GSH-targeted nanosponges increase doxorubicin-induced toxicity “in vitro” and “in vivo” in cancer cells with high antioxidant defenses 2016 ·Free Radical Biology and Medicine ·Martina Daga, Chiara Ullio, Monica Argenziano, Chiara Dianzani, Roberta Cavalli, Francesco Trotta, Carlo Ferretti, Gian Paolo Zara, Casimiro Luca Gigliotti, Eric Ciamporcero, Piergiorgio Pettazzoni, Denise Corti, Stefania Pizzimenti, Giuseppina Barrera	67
12	Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells 2016 ·Current Medicinal Chemistry ·Giuseppina Barrera, Martina Daga, Benedetta Ferrara, Chiara Dianzani, Stefania Pizzimenti, Monica Argenziano, Roberta Cavalli, Francesco Trotta	7
13	Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products 2016 ·Antioxidants ·Giuseppina Barrera, Fabrizio Gentile, Stefania Pizzimenti, Rosa Angela Canuto, Martina Daga, Alessia Arcaro, Giovanni Paolo Cetrangolo, Alessio Lepore, Carlo Ferretti, Chiara Dianzani, Giuliana Muzio	75
14	Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines 2015 ·Oxidative Medicine and Cellular Longevity ·Alessia Arcaro, Martina Daga, Giovanni Paolo Cetrangolo, Eric Ciamporcero, Alessio Lepore, Stefania Pizzimenti, (unknown), Graf M, Kôji Uchida, Gianfranco Mamone, Pasquale Ferranti, Paul R. J. Ames, Giuseppe Palumbo, Giuseppina Barrera, Fabrizio Gentile	8
15	YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage 2015 ·Oncogene ·Eric Ciamporcero, He Shen, Swathi Ramakrishnan, Sheng‐Yu Ku, Sreenivasulu Chintala, Li Shen, (unknown), Kiersten Marie Miles, Chiara Ullio, Stefania Pizzimenti, Martina Daga, Gissou Azabdaftari, Kristopher Attwood, Candace S. Johnson, (unknown), Giuseppina Barrera, Роберто Пили	108
16	Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 2015 ·Journal of Biomedical Nanotechnology ·Stefania Pizzimenti, Martina Daga, Eric Ciamporcero, Cristina Toaldo, Piergiorgio Pettazzoni, Simona Osella‐Abate, Mauro Novelli, Rosalba Minelli, Agnese Bisazza, Paola Gamba, Gabriella Testa, Chiara Ullio, Paolo Ferruti, Elisabetta Ranucci, Maria Grazia Bernengo, Carlo Ferretti, Chiara Dianzani, Fiorella Biasi, Giuseppina Barrera, Roberta Cavalli	7
17	Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases 2014 ·Antioxidants and Redox Signaling ·Giuseppina Barrera, Stefania Pizzimenti, Eric Ciamporcero, Martina Daga, Chiara Ullio, Alessia Arcaro, Giovanni Paolo Cetrangolo, Carlo Ferretti, Chiara Dianzani, Alessio Lepore, Fabrizio Gentile	109
18	Drug Delivery Nanoparticles in Skin Cancers 2014 ·BioMed Research International ·Chiara Dianzani, Gian Paolo Zara, Giovanni Maina, Piergiorgio Pettazzoni, Stefania Pizzimenti, Federica Rossi, Casimiro Luca Gigliotti, Eric Ciamporcero, Martina Daga, Giuseppina Barrera	126
19	Interaction of aldehydes derived from lipid peroxidation and membrane proteins 2013 ·Frontiers in Physiology ·Stefania Pizzimenti, Eric Ciamporcero, Martina Daga, Piergiorgio Pettazzoni, Alessia Arcaro, (unknown), Rosalba Minelli, Chiara Dianzani, Alessio Lepore, Fabrizio Gentile, Giuseppina Barrera	288
20	The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 2013 ·Free Radical Biology and Medicine ·Stefania Pizzimenti, Eric Ciamporcero, Piergiorgio Pettazzoni, Simona Osella‐Abate, Mauro Novelli, Cristina Toaldo, (unknown), Martina Daga, Rosalba Minelli, Agnese Bisazza, Paolo Ferruti, Elisabetta Ranucci, Maria Grazia Bernengo, Chiara Dianzani, Fiorella Biasi, Roberta Cavalli, Giuseppina Barrera	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact